Docetaxel (TaxotereTM) is active in non-small-cell lung cancer: a phase II trial of the EORTC early clinical trials group (ECTG)

1994161 citationsJournal Articlebronze Open Access

Authors

Good health and well-being

Published in: British Journal of Cancer

Volume 70, Issue 2, pp. 384-387

Field-Weighted Citation Impact: 8.61